OCUGEN INC has a total of 16 patent applications. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are EUROCINE AB, ONXEO and SERUM INST OF INDIA PRIVATE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Arumugham Rasappa | 14 |
#2 | Upadhyay Arun | 9 |
#3 | Musunuri Shankar | 5 |
#4 | Upadhyay Arun K | 5 |
#5 | Jain Sandeep | 5 |
#6 | Somasekhar Gopalam | 4 |
#7 | Nudell Matthew | 4 |
#8 | Haider Neena B | 3 |
#9 | Haider Neena | 1 |
#10 | Uday Bhaskar Kompella | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020047197A1 | Ophthalmic compositions and methods of use | |
WO2020222858A1 | Adeno-associated virus vector mediated gene therapy for ophthalmic diseases | |
US2019008920A1 | Ophthalmic compositions and methods of use | |
US2018333357A1 | Nanoemulsions with anti-inflammatory activity | |
CN110996904A | Ophthalmic compositions and methods of use | |
US2018221278A1 | Prsustained release opthalmic formuation and methods for using the same |